ikzser54

Property	Value
?:abstract	Interstitial pneumonia was the first manifestation to be recognized as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, in just a few weeks, it became clear that the coronavirus disease-2019 (COVID-19) overrun tissues and more body organs than just the lungs, so much so that it could be considered a systemic pathology. Several studies reported the involvement of the conjunctiva, the gut, the heart and its pace, and vascular injuries such as thromboembolic complications and Kawasaki disease in children and toddlers were also described. More recently, it was reported that in a sample of 214 SARS-CoV-2 positive patients, 36.4% complained of neurological symptoms ranging from non-specific manifestations (dizziness, headache, and seizures), to more specific symptoms such hyposmia or hypogeusia, and stroke. Older individuals, especially males with comorbidities, appear to be at the highest risk of developing such severe complications related to the Central Nervous System (CNS) involvement. Neuropsychiatric manifestations in COVID-19 appear to develop in patients with and without pre-existing neurological disorders. Growing evidence suggests that SARS-CoV-2 binds to the human Angiotensin-Converting Enzyme 2 (ACE2) for the attachment and entrance inside host cells. By describing ACE2 and the whole Renin Angiotensin Aldosterone System (RAAS) we may better understand whether specific cell types may be affected by SARS-CoV-2 and whether their functioning can be disrupted in case of an infection. Since clear evidences of neurological interest have already been shown, by clarifying the topographical distribution and density of ACE2, we will be able to speculate how SARS-CoV-2 may affect the CNS and what is the pathogenetic mechanism by which it contributes to the specific clinical manifestations of the disease. Based on such evidences, we finally hypothesize the process of SARS-CoV-2 invasion of the CNS and provide a possible explanation for the onset or the exacerbation of some common neuropsychiatric disorders in the elderly including cognitive impairment and Alzheimer disease.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C0009566> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C0012833> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C0018681> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C0036572> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C0178324> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C0235031> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C0338656> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C1457887> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C2364082> <https://research.tib.eu/covid-19/entity/ikzser54_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Panariello%2C_Fabio%3B_Cellini%2C_Lorenzo%3B_Speciani%2C_Maurizio%3B_De_Ronchi%2C_Diana%3B_Atti%2C_Anna_Rita>
?:journal	Front_Psychiatry
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/ikzser54_HAS_C5203676_CAUSES_C0206061>
?:source	WHO
?:title	How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#961659
?:year	2020

Property

Value

?:abstract

Interstitial pneumonia was the first manifestation to be recognized as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, in just a few weeks, it became clear that the coronavirus disease-2019 (COVID-19) overrun tissues and more body organs than just the lungs, so much so that it could be considered a systemic pathology. Several studies reported the involvement of the conjunctiva, the gut, the heart and its pace, and vascular injuries such as thromboembolic complications and Kawasaki disease in children and toddlers were also described. More recently, it was reported that in a sample of 214 SARS-CoV-2 positive patients, 36.4% complained of neurological symptoms ranging from non-specific manifestations (dizziness, headache, and seizures), to more specific symptoms such hyposmia or hypogeusia, and stroke. Older individuals, especially males with comorbidities, appear to be at the highest risk of developing such severe complications related to the Central Nervous System (CNS) involvement. Neuropsychiatric manifestations in COVID-19 appear to develop in patients with and without pre-existing neurological disorders. Growing evidence suggests that SARS-CoV-2 binds to the human Angiotensin-Converting Enzyme 2 (ACE2) for the attachment and entrance inside host cells. By describing ACE2 and the whole Renin Angiotensin Aldosterone System (RAAS) we may better understand whether specific cell types may be affected by SARS-CoV-2 and whether their functioning can be disrupted in case of an infection. Since clear evidences of neurological interest have already been shown, by clarifying the topographical distribution and density of ACE2, we will be able to speculate how SARS-CoV-2 may affect the CNS and what is the pathogenetic mechanism by which it contributes to the specific clinical manifestations of the disease. Based on such evidences, we finally hypothesize the process of SARS-CoV-2 invasion of the CNS and provide a possible explanation for the onset or the exacerbation of some common neuropsychiatric disorders in the elderly including cognitive impairment and Alzheimer disease.

is ?:annotates of